エソテリック検査の世界市場：2024年～2031年

エソテリック検査市場規模、シェア、動向分析レポート：検査タイプ別（感染症検査、腫瘍学検査、内分泌学検査、遺伝子検査、毒性学検査、神経学検査、その他）、技術別（酵素結合免疫吸着測定法、化学発光免疫測定法、質量分析法、DNAシークエンシング、フローサイトメトリー、その他）、エンドユーザー別（病院ベースのラボ、独立系・リファレンスラボ）予測期間（2024年～2031年）

エソテリック検査市場は予測期間（2024年～2031年）にCAGR 11.0％で成長すると予測されます。希少な分子や物質を分析するエソテリック検査は、病態の正確な診断に役立ち、早期介入、適切な治療、患者の転帰改善につながります。エソテリック検査市場の成長は、複雑な病状を特定し個別化治療を導くための希少疾患の診断需要の増加とともに、がんや感染症の有病率の増加が牽引しています。

市場力学

診断業界における技術革新の高まり

世界的に、慢性疾患の有病率が大幅に増加しており、これが診断業界の成長とイノベーションに拍車をかけています。市場は、研究活動の成長と相まって、難解な検査に対する大きな需要を目の当たりにしており、市場の成長に寄与しています。例えば、2023年6月、SRL Diagnostics社はインドのチェンナイに最先端のリファレンスラボを開設しました。この研究所は20,000平方メートルの敷地に拡張され、ルーチン検査、難解な検査、遺伝子検査など、毎月1,000件以上の検査を実施する能力を備えています。

さらに、より迅速で正確な難解な検査方法や機器の開拓などの技術的進歩が市場成長をさらに促進します。例えば、2023年7月、Novatein Biosciences社はヒト抗カルバミル化タンパク質抗体（抗CarP）ELISAキットを発売しました。このキットは、タンパク質のカルボニル化と様々な病態生理学的状態におけるその意味合いに関する革新的な研究を促進するように設計されています。

がんと感染症の有病率の増加

がんやHIV、連鎖球菌性咽頭炎などの様々な感染症の有病率が着実に上昇していることも、世界のエソテリック検査需要を支える要因の一つです。世界保健機関（WHO）によると、2022年末現在、世界全体で約3,900万人がHIVとともに暮らしています。さらに、流行以来、8,560万人以上がHIVに感染しています。これとは別に、同じ情報源によれば、がんは世界の死亡原因の第1位で、2022年には1,000万人が死亡すると推定されています。さらに、世界で約230万人と220万人がそれぞれ乳がんと肺がんと診断されています。

市場セグメンテーション

世界のエソテリック検査市場を詳細に分析した結果、検査タイプ別、技術別、エンドユーザー別に以下のように区分された：

• 検査タイプに基づき、市場は感染症検査、腫瘍学検査、内分泌学検査、遺伝子検査、毒物学検査、神経学検査、その他の検査（免疫学検査）に細分化されます。
• 技術別では、酵素結合免疫吸着測定法、化学発光免疫測定法、質量分析法、DNAシークエンシング、フローサイトメトリー、その他（ラジオイムノアッセイ、リアルタイムポリメラーゼ連鎖反応（PCR））に細分化されます。
• エンドユーザーに基づき、市場は病院ベースの検査室と独立系・レファレンス検査室に二分されます。

感染症が最大セグメントとなる見込み

この成長を支えているのは、世界中で感染症が急増していることと、呼吸器疾患を診断するための高度で革新的な難解な検査キットの開発が進んでいることです。例えば、2024年3月、Launch Diagnostics社は、感染症血清検査用のVirClia Lotus Chemiluminescence装置を発表しました。これは、検査室が難解で少量の感染症血清検査を実施することを可能にする単検査ソリューションです。さらに、米国食品医薬品局（US FDA）は、COVID-19と一致する呼吸器ウイルス感染症の症状を持つほぼすべての年齢層に対して、いくつかの家庭用キットソリューションも承認しています。承認されたキットには、LabCorp COVID-19+Flu+RSV、LabCorp Seasonal Respiratory Virus RT-PCR DTC、LabCorp COVID-19+Flu+RSVなどがあります。

地域別の展望

世界のエソテリック検査市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。

アジア太平洋経済圏でヘルスケアインフラが急成長

NITI Aayog Investment Gridが発表したレポートによると、国内の病院・医療インフラ・サブセクターには320億米ドル相当の投資機会が600件近くあります。さらに、診断検査の分野では、先進的で革新的な検査キットの国内製造を強化する計り知れない可能性があります。

最近、2023年11月、エソテリックIIは、インドグリッドトラストの持株会社となる投資持株会社としてシンガポールで設立されました。これはKKRPの関連会社であり、2023年9月の優先割当増資後、エソテリックの持ち株比率は22.7%となっています。

エソテリック試験の世界地域別市場成長率 2024年～2031年

北米が主要市場シェアを占める

すべての地域の中で、北米地域が世界市場の主要シェアを占めると予想されます。同地域は、老人や慢性疾患患者の膨大な人口基盤を保有しています。オックスフォードアカデミックによると、カナダは高齢化が進んでおり、65歳以上の人口の割合（17.7％）は米国よりも高いです。さらに、85歳以上の人口の割合が最も高い（2.7％）。この年齢層の大きさは、高齢者人口のヘルスケアに対する全体的なニーズを示す重要な指標となります。

世界のエソテリック検査市場に参入している主要企業には、ラボラトリー・コープ（Labcorp）/ラボラトリー・コープ・オブ・アメリカ、OPKOヘルス社、クエスト・ダイアグノスティックス、F.ホフマン・ラ・ロシュ社、メイヨー・クリニック（メイヨー医学教育研究財団）などがあります。市場競争力を維持するために、提携、合併、買収などの戦略を適用して事業拡大や製品開拓に注力する企業が増えています。例えば、2023年12月、ARUP LaboratoriesはMedicoverと提携し、欧州連合（EU）で新しいコンパニオン診断薬と遺伝子治療薬を発売しました。それ以前には、BioMarin Pharmaceutical Inc.と共同で、ROCTAVIAN（TM）による治療の対象となる重度の血友病A成人患者の選択を支援する診断キット、AAV5 DetectDxを開発しました。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Laboratory Corp.（Labcorp）/Laboratory Corp. of America
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• OPKO Health, Inc.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Quest Diagnostics
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• エソテリック検査の世界市場：検査タイプ別
  • 感染症検査
  • 腫瘍学検査
  • 内分泌学検査
  • 遺伝子検査
  • 毒物学検査
  • 神経学検査
  • その他の検査（免疫学検査）
• エソテリック検査の世界市場：技術別
  • 酵素結合免疫吸着測定法
  • 化学発光免疫測定法
  • 質量分析
  • DNAシーケンシング
  • フローサイトメトリー
  • その他（ラジオイムノアッセイ、リアルタイムポリメラーゼ連鎖反応（PCR））
• エソテリック検査の世界市場：エンドユーザー別
  • 病院ベースの検査室
  • 独立系およびリファレンス検査室

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• ARUP Laboratories
• Athena Esoterix, LLC
• Augusta University（Georgia Esoteric and Molecular Laboratory）
• bioMONTR（R）Labs, a division of McClernon LLC
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Fulgent Genetics, Inc.
• Grifols International, S.A.
• H.U. Group Holdings, Inc.
• Kindstar Globalgene Technology, Inc.
• Mayo Clinic（Mayo Foundation for Medical Education and Research）
• Nordic Laboratories（Nordic Group）
• Sonic Healthcare Ltd.
• Stanford Health Care
• Thyrocare Technologies Ltd.

LIST OF TABLES

• 1.GLOBAL ESOTERIC TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2023-2031 ($ MILLION)
• 2.GLOBAL ESOTERIC INFECTIOUS DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3.GLOBAL ESOTERIC ONCOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4.GLOBAL ESOTERIC ENDOCRINOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5.GLOBAL ESOTERIC GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 6.GLOBAL ESOTERIC TOXICOLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 7.GLOBAL ESOTERIC NEUROLOGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8.GLOBAL OTHER ESOTERIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9.GLOBAL ESOTERIC TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
• 10.GLOBAL ESOTERIC TESTING FOR ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 11.GLOBAL ESOTERIC TESTING FOR CHEMILUMINESCENCE IMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 12.GLOBAL ESOTERIC TESTING FOR MASS SPECTROMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 13.GLOBAL ESOTERIC TESTING FOR DNA SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 14.GLOBAL ESOTERIC TESTING FOR FLOW CYTOMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 15.GLOBAL ESOTERIC TESTING FOR OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 16.GLOBAL ESOTERIC TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 17.GLOBAL ESOTERIC TESTING BY HOSPITAL-BASED LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 18.GLOBAL ESOTERIC TESTING FOR INDEPENDENT AND REFERENCE LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 19.GLOBAL BIOREFINERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 20.NORTH AMERICAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 21.NORTH AMERICAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2023-2031 ($ MILLION)
• 22.NORTH AMERICAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
• 23.NORTH AMERICAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 24.EUROPEAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 25.EUROPEAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2023-2031 ($ MILLION)
• 26.EUROPEAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
• 27.EUROPEAN BIOREFINERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 28.ASIA-PACIFIC BIOREFINERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 29.ASIA-PACIFIC BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2023-2031 ($ MILLION)
• 30.ASIA-PACIFIC BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
• 31.ASIA-PACIFIC BIOREFINERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 32.REST OF THE WORLD BIOREFINERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 33.REST OF THE WORLD BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2023-2031 ($ MILLION)
• 34.REST OF THE WORLD BIOREFINERY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2023-2031 ($ MILLION)
• 35.REST OF THE WORLD BIOREFINERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1.GLOBAL ESOTERIC TESTING MARKET SHARE BY TEST TYPE, 2023 VS 2031 (%)
• 2.GLOBAL ESOTERIC INFECTIOUS DISEASE TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 3.GLOBAL ESOTERIC ONCOLOGY TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 4.GLOBAL ESOTERIC ENDOCRINOLOGY TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 5.GLOBAL ESOTERIC GENETIC TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 6.GLOBAL ESOTERIC TOXICOLOGY TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 7.GLOBAL ESOTERIC NEUROLOGY TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 8.GLOBAL OTHER ESOTERIC TESTING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 9.GLOBAL ESOTERIC TESTING MARKET SHARE BY TECHNOLOGY, 2023 VS 2031 (%)
• 10.GLOBAL ESOTERIC TESTING FOR ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 11.GLOBAL ESOTERIC TESTING FOR CHEMILUMINESCENCE IMMUNOASSAY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 12.GLOBAL ESOTERIC TESTING FOR MASS SPECTROMETRY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 13.GLOBAL ESOTERIC TESTING FOR DNA SEQUENCING MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 14.GLOBAL ESOTERIC TESTING FOR FLOW CYTOMETRY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 15.GLOBAL ESOTERIC TESTING FOR OTHER TECHNOLOGIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 16.GLOBAL ESOTERIC TESTING MARKET SHARE BY END-USER, 2023 VS 2031 (%)
• 17.GLOBAL ESOTERIC TESTING FOR HOSPITAL-BASED LABORATORIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 18.GLOBAL ESOTERIC TESTING FOR INDEPENDENT AND REFERENCE LABORATORIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 19.GLOBAL BIOREFINERY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 20.US BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 21.CANADA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 22.UK BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 23.FRANCE BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 24.GERMANY BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 25.ITALY BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 26.SPAIN BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 27.REST OF EUROPE BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 28.INDIA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 29.CHINA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 30.JAPAN BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 31.SOUTH KOREA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 32.REST OF ASIA-PACIFIC BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 33.LATIN AMERICA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)
• 34.THE MIDDLE EAST AND AFRICA BIOREFINERY MARKET SIZE, 2023-2031 ($ MILLION)

Esoteric Testing Market Size, Share & Trends Analysis Report by Test Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology, Neurology Testing, and Others), By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, DNA Sequencing, Flow Cytometry, Others), and by End-User (Hospital-based Laboratories and Independent and Reference Laboratories) Forecast Period (2024-2031)

Esoteric testing market is anticipated to grow at a CAGR of 11.0% during the forecast period (2024-2031). Esoteric testing, which analyzes rare molecules or substances, can help diagnose conditions accurately, leading to early intervention, proper treatment, and improved patient outcomes. The esoteric testing market growth is driven by the increasing prevalence of cancer and infectious diseases along with the growing demand for diagnosis of rare diseases to identify complex medical conditions and guide personalized treatment.

Market Dynamics

Growing Innovations in the Diagnostic Industry

Globally, there is a considerable increase in the prevalence of chronic diseases, which in turn spurred growth and innovations in the diagnostic industry. The market has witnessed a significant demand for esoteric testing coupled with growth in research activities contributing to the market growth. For instance, in June 2023, SRL Diagnostics launched a state-of-the-art reference laboratory in Chennai, India. The laboratory is expanded over 20,000 sq ft along with the capability to conduct more than 1 lakh tests monthly, including routine tests, esoteric tests, and genetic tests.

Additionally, technological advancements, such as the development of more fast and accurate esoteric testing methods & instruments further drive the market growth. For instance, in July 2023, Novatein Biosciences launched its Human Anti-Carbamylated Protein Antibody (Anti-CarP) ELISA Kit. This kit is designed to facilitate innovative research in protein carbonylation and its implications in various pathophysiological conditions.

Increasing Prevalence of Cancer & Infectious Diseases

The steadily rising prevalence of cancer and various infectious diseases such as HIV, strep throat, and others is another factor supporting the esoteric testing demand globally. According to the World Health Organization (WHO), globally, around 39.0 million people were living with HIV at the end of 2022. Furthermore, since the epidemic, over 85.6 million people have been infected with HIV. Apart from this, as per the same source, cancer was estimated to be the leading cause of fatalities globally, accounting for 10 million fatalities in 2022. In addition, about 2.3 million and 2.2 million people worldwide were diagnosed with breast cancer and lung cancer, respectively.

Market Segmentation

Our in-depth analysis of the global esoteric testing market includes the following segments by test type, technology, and end-user:

• Based on test type, the market is sub-segmented into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, neurology testing, and other testing (immunology testing).
• Based on technology, the market is sub-segmented into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass spectrometry, DNA sequencing, flow cytometry, and others (radioimmunoassay, real-time polymerase chain reaction (PCR).
• Based on end-user, the market is bifurcated into hospital-based laboratories and independent and reference laboratories

Infectious Diseases is Projected to Emerge as the Largest Segment

The growth is supported owing to the surging prevalence of infectious diseases around the globe along with the growing development of advanced and innovative esoteric testing kits for diagnosing respiratory diseases. For instance, in March 2024, Launch Diagnostics introduced the VirClia Lotus Chemiluminescence instrument for infectious diseases serology. It is a mono-test solution that allows the laboratory to run esoteric and low-volume infectious serology tests. Moreover, the US Food and Drug Administration (US FDA) has also approved several home kit solutions for almost every age group with symptoms of respiratory viral infection consistent with COVID-19. Some of the approved kits include LabCorp COVID-19+Flu+RSV, LabCorp Seasonal Respiratory Virus RT-PCR DTC, LabCorp COVID-19+Flu+RSV, and others.

Regional Outlook

The global esoteric testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

Rapidly Growing Healthcare Infrastructure Among the Asia-Pacific Economies

As per the report published by NITI Aayog Investment Grid, there are nearly 600 investment opportunities worth $32 billion in the country's hospital and medical infrastructure sub-sector. Additionally, in the field of diagnostic testing, the country has immense potential to bolster domestic manufacturing of advanced and innovative test kits.

Recently, in November 2023, Esoteric II was incorporated in Singapore as an investment holding company to be the holding company for India Grid Trust. It is an affiliate of KKRPost the preferential allotment in September 2023, Esoteric's stake stands at 22.7%.

Global Esoteric Testing Market Growth by Region 2024-2031

Source: OMR Analysis

North America Holds Major Market Share

Among all the regions, the North American region is expected to hold a major share of the global market. The region holds a huge population base of geriatric and chronic disease people. According to the Oxford Academic, Canada is an older country with a percentage of the population aged 65 years and above (17.7%) than in the US. Additionally, it has the highest percentage of its population aged above 85 years (2.7%). The size of this age group is an important indicator of the overall need for healthcare in the older population.

Market Players Outlook

Note: Major Players Sorted in No Particular Order.

The major companies serving the global esoteric testing market include Laboratory Corp. (Labcorp)/ Laboratory Corp. of America, OPKO Health, Inc., Quest Diagnostics, F. Hoffmann-La Roche Ltd., and Mayo Clinic (Mayo Foundation for Medical Education and Research), among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in December 2023, ARUP Laboratories partnered with Medicover to release a new companion diagnostic and gene therapy in the European Union. Earlier in collaboration with BioMarin Pharmaceutical Inc. developed AAV5 DetectDx , a diagnostic kit that aids in the selection of adult patients with severe hemophilia A who are eligible for treatment with ROCTAVIAN(TM)

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global esoteric testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.Laboratory Corp. (Labcorp)/ Laboratory Corp. of America
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.OPKO Health, Inc.
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.Quest Diagnostics
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Esoteric Testing Market by Test Type
  • 4.1.1.Infectious Disease Testing
  • 4.1.2.Oncology Testing
  • 4.1.3.Endocrinology Testing
  • 4.1.4.Genetic Testing
  • 4.1.5.Toxicology Testing
  • 4.1.6.Neurology Testing
  • 4.1.7.Other Testing (Immunology Testing)
• 4.2.Global Esoteric Testing Market by Technology
  • 4.2.1.Enzyme-linked Immunosorbent Assay
  • 4.2.2.Chemiluminescence Immunoassay
  • 4.2.3.Mass Spectrometry
  • 4.2.4.DNA Sequencing
  • 4.2.5.Flow Cytometry
  • 4.2.6.Others (Radio Immunoassays, Real Time Polymerase Chain Reaction (PCR))
• 4.3.Global Esoteric Testing Market by End-User
  • 4.3.1.Hospital-based Laboratories
  • 4.3.2.Independent and Reference Laboratories

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World
  • 5.4.1.Latin America
  • 5.4.2.Middle East and Africa

6.Company Profiles

• 6.1.ARUP Laboratories
• 6.2.Athena Esoterix, LLC
• 6.3.Augusta University (Georgia Esoteric and Molecular Laboratory)
• 6.4.bioMONTR(R) Labs, a division of McClernon LLC
• 6.5.Eurofins Scientific
• 6.6.F. Hoffmann-La Roche Ltd.
• 6.7.Fulgent Genetics, Inc.
• 6.8.Grifols International, S.A.
• 6.9.H.U. Group Holdings, Inc.
• 6.10.Kindstar Globalgene Technology, Inc.
• 6.11.Mayo Clinic (Mayo Foundation for Medical Education and Research)
• 6.12.Nordic Laboratories (Nordic Group)
• 6.13.Sonic Healthcare Ltd.
• 6.14.Stanford Health Care
• 6.15.Thyrocare Technologies Ltd.